Fullerenol nanoparticles: Toxicity and antioxidant activity

Methods in Molecular Biology

Volumn 1028, Issue , 2013, Pages 75-100

  Injac, Rade ^a   Prijatelj, Matevz ^a   Strukelj, Borut ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Antioxidant; Bioapplication; Fullerene; Fullerenol; Nanoparticles; Toxicity

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; CYTOSTATIC AGENT; DOXORUBICIN; FULLERENE DERIVATIVE; FULLERENOL; GADOLINIUM ENDOHEDRAL METALLOFULLERENOL; NANOPARTICLE; UNCLASSIFIED DRUG;

ACUTE TOXICITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; BIOLOGICAL ACTIVITY; CHEMICAL STRUCTURE; DRUG DELIVERY SYSTEM; HUMAN; IC 50; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; METASTASIS INHIBITION; NONHUMAN; PRIORITY JOURNAL; REVIEW; TUMOR CELL LINE;

EID: 84883247560     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-475-3_5     Document Type: Review

References (77)

1. Djordjevic A, Bogdanovic G, Dobric S (2006) Fullerenes in biomedicine. J BUON 11:391-404
2. Injac R, Kocevar N, Strukelj B (2008) Fullerenol C 60 (OH) 24 as potential drug. Farm Vest 59:257-262
3. Injac R, Strukelj B (2008) Recent advances in protection against doxorubicin-induced toxicity. Technol Cancer Res Treat 7:497-516
4. Injac R, Radic N, Govedarica B et al (2008) Bioapplication and activity of fullerenol C 60 (OH) 24 . Afr J Biotechnol 25:4940-4950
5. Deguchi S, Alargova RG, Tsujii K (2001) Stable dispersions of fullerenes, C-60 and C-70, in water. Preparation and characterization Langmuir 17:6013-6017
6. Makha M, Purich A, Raston CL et al (2006) Structural diversity of host-guest and intercalation complexes of fullerene C 60 . Eur J Inorg Chem 37:507-515
7. Husebo LO, Sitharaman B, Furukawa T et al (2004) Fullerenols revisited as stable radical anions. J Am Chem Soc 126:12055-12064
8. Brant JA, Labille J, Bottero J et al (2006) Characterizing the impact of preparation method on fullerene cluster structure and chemistry. Langmuir 22:3878-3885
9. Gao Y, Tang Z, Watkins E et al (2005) Synthesis and characterization of amphiphilic fullerenes and their Langmuir-Blodgett fi lms. Langmuir 21:1416-1423
10. Brant JA, Labille J, Robichaud CO et al (2007) Fullerol cluster formation in aqueous solutions: Implications for environmental release. J Colloid Interface Sci 314:281-288
11. Vileno B, Sienkiewicz A, Lekka M et al (2004) In vitro assay of singlet oxygen generation in presence of water-soluble derivatives of C 60 . Carbon 42:1195-1198
12. Zhao B, He Z, Bilsk PJ et al (2008) Pristine (C 60) and hydroxylated [C 60 (OH) 24 ] fullerene phototoxicity towards HaCaT keratinocytes: Type I vs Type II mechanisms. Chem Res Toxicol 21:1056-1063
13. Nagano T, Arakane K, Ryu A et al (1994) Comparison of singlet oxygen production effi-ciency of C-60 with other photosensitizers, based on 1268-Nm emission. Chem Pharm Bull 42:2291-2294
14. Sera N, Tokiwa H, Miyata N (1996) Mutagenicity of the fullerene C 60-generated singlet oxygen dependent formation of lipid peroxides. Carcinogenesis 17:2163-2169
15. Nakanishi I, Ohkubo K, Fujita S et al (2002) Direct detection of superoxide anion generated in C-60-photosensitized oxidation of NADH and an analogue by molecular oxygen. J Chem Soc Perkin Trans 2:1829-1833
16. Nakanishi I, Fukuzumi S, Konishi T et al (2002) DNA cleavage via superoxide anion formed in photoinduced electron transfer from NADH to gamma-cyclodextrin-bicapped C-60 in an oxygen-saturated aqueous solution. J Phys Chem B 106:2372-2380
17. 2 . J Am Chem Soc 125:12803-12809
18. Tokuyama H, Yamago S, Nakamura E et al (1993) Photoinduced biochemical-Activity of fullerene carboxylic-Acid. J Am Chem Soc 115:7918-7919
19. Markovic Z, Trajkovic V (2008) Biomedical potential of the reactive oxygen species generation and quenching by fullerenes (C 60) . Biomaterials 29:3561-3573
20. Injac R, Perse M, Cerne M et al (2009) Protective effects of fullerenol C 60 (OH) 24 against doxorubicin-induced cardiotoxicity and hepatotoxicity in rats with colorectal cancer. Biomaterials 30:1184-1196
21. Injac R, Perse M, Obermajer N et al (2008) Potential hepatoprotective effects of fullerenol C 60 (OH) 24 in doxorubicin-induced hepatotoxicity in rats with mammary carcinomas. Biomaterials 29:3451-3460
22. Injac R, Perse M, Boskovic M et al (2008) Cardioprotective effects of fullerenol C 60 (OH) 24 on a single dose doxorubicininduced cardiotoxicity in rats with malignant neoplasm. Technol Cancer Res Treat 7:15-25
23. Injac R, Boskovic M, Perse M et al (2008) Acute doxorubicin nephrotoxicity in rats with malignant neoplasm can be successfully treated with fullerenol C 60 (OH) 24 via suppression of oxidative stress. Pharmacol Rep 5:742-749
24. Injac R, Radic N, Govedarica B et al (2009) Acute doxorubicin pulmotoxicity in rats with malignant neoplasm is effectively treated with fullerenol C 60 (OH) 24 through inhibition of oxidative stress. Pharmacol Rep 2:335-342
25. Djordjevic-Milic V, Djordjevic A, Dobric S et al (2006) Infl uence of fullerenol C 60 (OH) 24 on doxorubicin induced cardiotoxicity in rats. Mater Sci Forum 518:525-529
26. Djordjevic-Milic V, Stankov K, Injac R et al (2009) Activity of antioxidative enzymes in erythrocytes after a single dose administration of doxorubicin in rats pretreated with fullerenol C 60 (OH) 24 . Toxicol Mech Methods 19:24-28
27. Injac R, Djordjevic A, Strukelj B (2008) Doxorubicin-induced myocardial failure in rats with malignant neoplasm: Protective role of fullerenol C 60 (OH) 24 . Hem Ind 62:197-204
28. Dragojevic-Simic V, Jacevic V, Dobric S et al (2011) Anti-infl ammatory activity of fullerenol C 60 (OH) 24 nano-particles in a model of acute infl ammation in rats. Dig J Nanomater Bios 6:819-827
29. Djordjevic A, Canadanovic-Brunet J, Vojinovic-Miloradov M et al (2005) Antioxidant properties and hypothetical radical mechanism of fullerenol C 60 (OH) 24 . Oxid Commun 4: 806-812
30. Mirkov S, Djordjevic A, Andric N et al (2004) Nitric oxide scavenging activity of polyhydroxylated fullerenol, C 60 (OH) 24 . Nitric Oxide 11:201-207
31. Fileti EE, Rivelino R, de Brito Mota F et al (2008) Effects of hydroxyl group distribution on the reactivity, stability and optical properties of fullerenols. Nanotechnology 19:365703
32. Chen YW, Hwang KC, Yen CC et al (2004) Fullerene derivatives protect against oxidative stress in RAW 264.7 cells and ischemiareperfused lungs. Am J Physiol Regul Integr Comp Physiol 287:R21-R26
33. Bogdanovic G, Kojic V, Djordjevic A et al (2004) Modulating activity of fullerol C 60 (OH) 22 on doxorubicin-induced cytotoxicity. Toxicol In Vitro 18:629-637
34. Lu LH, Lee YT, Chen HW et al (1998) The possible mechanism of the antiproliferative effects of fullerenol, polyhydroxylated C 60 on vascular smooth muscle cells. Br J Pharmacol 123:1097-1102
35. Kojic V, Jakimov D, Bogdanovic G et al (2005) Effects of fullerenol C 60 (OH) 24 on cytotoxicity induced by antitumor drugs on human breast carcinoma cell lines. Mater Sci Forum 492: 543-548
36. Foley S, Crowley C, Smaihi M et al (2002) Cellular localization of a water soluble fullerene derivative. Biochem Biophys Res Commun 294:116-119
37. Bergmeyer HU (1983) Methods of enzymatic analysis. Weinheim, Basel
38. Misra HP, Fridovich I (1972) The generation of superoxide radical during the autoxidation of hemoglobin. J Biol Chem 247:6960-6962
39. Beutler E (1984) Red cell metabolism. A Manual of Biochemical Methods, Grune & Stratton, New York
40. Niva Y, Iwai N (2006) Genotoxicity in cell lines induced by chronic exposure to watersoluble fullerenes using micronucleus test. Environ Health Prev Med 11:292-297
41. Zhao Q, Li Y, Xu J et al (2005) Radioprotection by fullerenols of Stylonychia mytilus exposed to gamma-rays. Int J Radiat Biol 81: 169-175
42. Daroczi B, Kari G, McAleer MF et al (2006) In vivo radioprotection by the fullerene nanoparticle DF-1 as assessed in a zebrafi sh model. Clin Cancer Res 12:7086-7091
43. Bogdanovic V, Stankov K, Icevic I et al (2008) Fullerenol C 60 (OH) 24 effects on antioxidative enzymes activity in irradiated human erythroleukemia cell line. J Radiat Res 49:321-327
44. Brant JA, Labile J, Robichaund CO et al (2007) Fullerol cluster formation in aqueous solutions: Implications for environmental release. J Colloid Interface Sci 314:281-288
45. Sayes CM, Gobin AM, Ausman KD et al (2005) Nano-C-60 cytotoxicity is due to lipid peroxidation. Biomaterials 26:7587-7595
46. Isakovic A, Markovic Z, Todorovic-Markovic B et al (2006) Distinct cytotoxic mechanisms of pristine versus hydroxylated fullerene. Toxicol Sci 91:173-183
47. Sayes C, Fortner J, Lyon D et al (2004) The differential cytotoxicity of water-soluble fullerenes. Nano Lett 4:1881-1887
48. Yamawaki H, Iwai N (2006) Cytotoxicity of water-soluble fullerene in vascular endothelial cells. Am J Physiol Cell Physiol 290: C1495-C1502
49. Ueng T-H, Kang J-J, Wang H-W et al (1997) Suppression of microsomal cytochrome P450-dependent monooxygenases and mitochondrial oxidative phosphorylation by fullerenol, a polyhydroxylated fullerene C 60 . Toxicol Lett 93:29-37
50. Su YY, Xu JY, Shen PP et al (2010) Cellular uptake and cytotoxic evaluation of fullerenol in different cell lines. Toxicology 269:155-159
51. Gelderman MP, Simakova O, Clogston JD et al (2008) Adverse effects of fullerenes on endothelial cells: Fullerenol C 60 (OH) 24 induced tissue factor and ICAM-1 membrane expression and apoptosis in vitro. Int J Nanomedicine 3:59-68
52. Burdon RH, Gill V (1993) Cellularly generated active oxygen species and HeLa cell proliferation. Free Radic Res Commun 19:203-213
53. Wei YH, Lee HC (2002) Oxidative stress, mitochondrial DNA mutation, and impairment of antioxidant enzymes in aging. Exp Biol Med 227:671-682
54. Tagmatarchis N, Shinohara H (2001) Fullerenes in medicinal chemistry and their biological applications. Mini Rev Med Chem 1:339-348
55. Lai HS, Chen Y et al (2000) Free radical scavenging activity of fullerenol on grafts after small bowel transplantation in dogs. Transplant Proc 32:1272-1274
56. Lai HS, Chen WJ et al (2000) Free radical scavenging activity of fullerenol on the ischemia-reperfusion intestine in dogs. World J Surg 24:450-454
57. Zimmermann C, Winnefeld K et al (2004) Antioxidant status in acute stroke patients and patients at stroke risk. Eur Neurol 51: 157-161
58. Johnson-Lyles DN, Peifley K, Lockett S et al (2010) Fullerenol cytotoxicity in kidney cells is associated with cytoskeleton disruption, autophagic vacuole accumulation, and mitochondrial dysfunction. Toxicol Appl Pharmacol 248:249-258
59. Buege AL, Aust DS (1978) Methods in enzymology. Academic, New York
60. Trajkovic S, Dobric S, Djordjevic A et al (2005) Radioprotective effi ciency of fullerenol in irradiated mice. Mater Sci Forum 494: 549-554
61. Trajkovic S, Dobric S, Jacevic V et al (2007) Tissue-protective effects of fullerenol C 60 (OH) 24 and amifostine in irradiated rats. Colloids Surf B Biointerfaces 58:39-43
62. Icevic I, Vukmirovic S, Srdjenovic B et al (2011) Protective effects of orally applied fullerenol nanoparticles in rats after a single dose of doxorubicin. Hem Ind 65:329-337
63. Maksim T, Djokic D, Jankovic D et al (2007) Comparison of some physico-chemical parameters and biological behaviour of fullerenol labelled with technetium-99 m. J Optoelectron Adv Mater 9:2571-2577
64. Zhu J, Ji Z, Wang J et al (2008) Tumorinhibitory effect and immunomodulatory activity of fullerenol C 60 (OH) x . Small 4:1168-1175
65. Wu XA, Yang ST, Wang HF et al (2010) Infl uences of the size and hydroxyl number of fullerenes/fullerenols on their interactions with proteins. J Nanosci Nanotechnol 10: 6298-6304
66. Jiao F, Liu Y, Qu Y et al (2010) Studies on anti-Tumor and antimetastatic activities of fullerenol in a mouse breast cancer model. Carbon 48:2231-2243
67. Xu J-Y, Han K, Li S-X et al (2009) Pulmonary responses to polyhydroxylated fullerenols, C 60 (OH) x . J Appl Toxicol 29:578-584
68. Chaudhuri P, Paraskar A, Soni S et al (2009) Fullerenol cytotoxic conjugates for cancer chemotherapy. ACS Nano 3:2505-2514
69. Liang X-J, Chen C, Zhao Y et al (2008) Biopharmaceutics and therapeutic potential of engineered nanomaterials. Curr Drug Metab 9:697-709
70. Wang J, Chen C, Li B et al (2006) Onedimensional metallofullerene crystal generated inside single-walled carbon nanotubes. Biochem Pharmacol 71:872-881
71. Watanabe T, Ichikawa H, Fukumori Y (2002) Tumor accumulation of gadolinium in lipidnanoparticles intravenously injected for neutron-capture therapy of cancer. Eur J Pharm Biopharm 54:119-124
72. Mikawa M, Kato H, Okumura M et al (2001) Paramagnetic water-soluble metallofullerenes having the highest relaxivity for MRI contrast agents. Bioconjug Chem 12:510-514
73. Sies H (1999) Glutathione and its role in cellular functions. Free Radic Biol Med 27: 916-921
74. Satoh M, Takayanagi I (2006) Pharmacological Studies on Fullerene (C 60) , a novel carbon allotrope, and Its derivatives. J Pharmacol Sci 100:513-518
75. Bossi S, Da Ros T, Spalluto G et al (2003) Fullerene derivatives: An attractive tool for biological applications. Eur J Med Chem 38: 913-923
76. Deguchi S, Mukai SA, Tsudome M et al (2006) Facile generation of fullerene nanoparticles by hand-grinding. Adv Mater 18:729-732
77. Brettreich M, Hirsch A (1998) A highly watersoluble dendro[60]fullerene. Tetrahedron Lett 39:2731-2734